Astrazeneca Memo Details Vaccine Patient Illness
INTERNAL ASTRAZENECA REPORT SHEDS LIGHT ON NEUROLOGICAL CONDITION SUFFERED BY CORONAVIRUS VACCINE CLINICAL TRIAL PARTICIPANT
(CNN) – There’s more information to report about what led to one of the major coronavirus vaccine trials being put on hold.
CNN obtained internal safety reports from vaccine maker Astrazeneca about the participant who suffered neurological complications.
The 37-year old British woman was given a confirmed diagnosis of transverse myelitis after getting a second dose of the vaccine.
It’s a rare neurological condition which involves inflammation of the spinal cord.
The vaccine recipient had trouble walking as well as symptoms of weakness and pain in her arms.
The patient’s condition appears to be getting better.
Doctor Anthony Fauci is calling it a “one off.”
That means it may not be related to her vaccine at all, or could be extremely rare.
Vaccine trials have resumed in the U.K. and are expected to re-start in the U.S. soon.
However, vaccine researchers are being asked to be on the lookout for any similar symptoms going forward.